NCT04454281View on ClinicalTrials.gov

Topical Naloxone to Diagnose Ocular Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 3, 2020

Study Completion Date

December 3, 2020

Conditions
Dry Eye SyndromesNeuropathic Pain
Interventions
DRUG

Naloxone Hydrochloride 0.4 MG/ML

Drug will be topically applied to the corneal surface then study evaluations will ensue.

Trial Locations (1)

40506

University of Kentucky, Lexington

All Listed Sponsors
lead

Seema Capoor

OTHER

NCT04454281 - Topical Naloxone to Diagnose Ocular Pain | Biotech Hunter | Biotech Hunter